Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 10, 2012
Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal disseminationMichiaki Kumagai, Shinya Shimoda, Rie Wakabayashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 10, 2020
Adult genitourinary sarcoma: The era of optional chemotherapeutic agents for soft tissue sarcomaTetsuya Urasaki, Kenji Nakano, Junichi Tomomatsu, et al.
Leukemia Research|January 18, 2011
Antitumor effects of YM155, a novel survivin suppressant, against human aggressive non-Hodgkin lymphomaAya Kita, Takahito Nakahara, Kentaro Yamanaka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2011
Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomasNoriko Nishimura, Kenji Nakano, Kyoko Ueda, et al.
Japanese Journal of Clinical Oncology|June 16, 2012
Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomasKenji Nakano, Shunji Takahashi, Takeshi Yuasa, et al.
Cancer Letters|October 29, 2003
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancerTakayuki Toyonaga, Kenji Nakano, Masahiro Nagano, et al.
Oncotarget|April 21, 2017
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancerMakoto Kawamoto, Hideya Onishi, Keigo Ozono, et al.
World Journal of Surgery|February 28, 2003
Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinomaTakayuki Toyonaga, Kazuo Chijiiwa, Kenji Nakano, et al.
Japanese Journal of Clinical Oncology|March 1, 2015
Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE studyKenji Nakano, Noriko Motoi, Lina Inagaki, et al.
Urology|February 15, 2011
Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancerTakeshi Yuasa, Shinji Urakami, Shinya Yamamoto, et al.
Pageof 15